Literature DB >> 10212315

Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury.

A Blesch1, H S Uy, R J Grill, J G Cheng, P H Patterson, M H Tuszynski.   

Abstract

The cytokine leukemia inhibitory factor (LIF) modulates glial and neuronal function in development and after peripheral nerve injury, but little is known regarding its role in the injured adult CNS. To further understand the biological role of LIF and its potential mechanisms of action after CNS injury, effects of cellularly delivered LIF on axonal growth, glial activation, and expression of trophic factors were examined after adult mammalian spinal cord injury. Fibroblasts genetically modified to produce high amounts of LIF were grafted to the injured spinal cords of adult Fischer 344 rats. Two weeks after injury, animals with LIF-secreting cells showed a specific and significant increase in corticospinal axon growth compared with control animals. Furthermore, expression of neurotrophin-3, but not nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor, or ciliary neurotrophic factor, was increased at the lesion site in LIF-grafted but not in control subjects. No differences in astroglial and microglial/macrophage activation were observed. Thus, LIF can directly or indirectly modulate molecular and cellular responses of the adult CNS to injury. These findings also demonstrate that neurotrophic molecules can augment expression of other trophic factors in vivo after traumatic injury in the adult CNS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212315      PMCID: PMC6782234     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Proliferation of ramified microglia on an astrocyte monolayer: characterization of stimulatory and inhibitory cytokines.

Authors:  C U Kloss; G W Kreutzberg; G Raivich
Journal:  J Neurosci Res       Date:  1997-07-15       Impact factor: 4.164

2.  Generation of sensory neurons is stimulated by leukemia inhibitory factor.

Authors:  M Murphy; K Reid; D J Hilton; P F Bartlett
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity.

Authors:  M Canossa; O Griesbeck; B Berninger; G Campana; R Kolbeck; H Thoenen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  Cytokines which signal through the LIF receptor and their actions in the nervous system.

Authors:  M Murphy; R Dutton; S Koblar; S Cheema; P Bartlett
Journal:  Prog Neurobiol       Date:  1997-08       Impact factor: 11.685

5.  Phenotypic alteration of astrocytes induced by ciliary neurotrophic factor in the intact adult brain, As revealed by adenovirus-mediated gene transfer.

Authors:  F Lisovoski; S Akli; E Peltekian; E Vigne; G Haase; M Perricaudet; P A Dreyfus; A Kahn; M Peschanski
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

Review 6.  Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology.

Authors:  P H Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

7.  Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain.

Authors:  M Minami; Y Kuraishi; M Satoh
Journal:  Biochem Biophys Res Commun       Date:  1991-04-30       Impact factor: 3.575

8.  Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation.

Authors:  T R Ulich; M J Fann; P H Patterson; J H Williams; B Samal; J Del Castillo; S Yin; K Guo; D G Remick
Journal:  Am J Physiol       Date:  1994-10

9.  Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines.

Authors:  M A Kahn; J De Vellis
Journal:  Glia       Date:  1994-10       Impact factor: 7.452

10.  Leukaemia inhibitory factor rescues motoneurones from axotomy-induced cell death.

Authors:  S S Cheema; L J Richards; M Murphy; P F Bartlett
Journal:  Neuroreport       Date:  1994-04-14       Impact factor: 1.837

View more
  30 in total

1.  NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.

Authors:  Leonard L Jones; Yu Yamaguchi; William B Stallcup; Mark H Tuszynski
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 2.  Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury.

Authors:  L L Jones; M Oudega; M B Bunge; M H Tuszynski
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

3.  Impact of treatment duration and lesion size on effectiveness of chondroitinase treatment post-SCI.

Authors:  S E Mondello; S C Jefferson; N J Tester; D R Howland
Journal:  Exp Neurol       Date:  2015-02-26       Impact factor: 5.330

4.  Neuroregenerative and protective functions of Leukemia Inhibitory Factor in perinatal hypoxic-ischemic brain injury.

Authors:  Jie Lin; Yusuke Niimi; Mariano Guardia Clausi; Hur Dolunay Kanal; Steven W Levison
Journal:  Exp Neurol       Date:  2020-04-19       Impact factor: 5.330

5.  Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection.

Authors:  Armen A Galoyan; John S Sarkissian; Vergine A Chavushyan; Ruben M Sulkhanyan; Zaruhi E Avakyan; Zubeida A Avetisyan; Yuri Kh Grigorian; Davit O Abrahamyan
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

Review 6.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

7.  Neurophysiological examination of the corticospinal system and voluntary motor control in motor-incomplete human spinal cord injury.

Authors:  W B McKay; D C Lee; H K Lim; S A Holmes; A M Sherwood
Journal:  Exp Brain Res       Date:  2004-12-23       Impact factor: 1.972

Review 8.  Growth factors and combinatorial therapies for CNS regeneration.

Authors:  Paul Lu; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2007-08-22       Impact factor: 5.330

9.  Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury.

Authors:  N Weidner; A Ner; N Salimi; M H Tuszynski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

10.  Intrinsic response of thoracic propriospinal neurons to axotomy.

Authors:  Justin R Siebert; Frank A Middelton; Dennis J Stelzner
Journal:  BMC Neurosci       Date:  2010-06-04       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.